They showed that rapamycin, an mTOR pathway inhibitor, combined with miR-34, a tumor-suppressive micro-RNA, associated with the regulation of stem-like cells in solid tumors, could overcome CSC-associated radioresistance. Here, MTOR is linked to neoplasm.